Can I Take Ashwagandha with Tretinoin?

At a glance
- Interaction risk / low (pharmacodynamic only, no shared metabolism)
- Tretinoin systemic absorption / <2% of applied dose reaches circulation
- Ashwagandha cortisol reduction / 23% mean decrease at 300 mg twice daily (Chandrasekhar 2012)
- Thyroid concern / ashwagandha raises T4 by ~19% in subclinical hypothyroid patients
- Shared hepatic pathway / both undergo CYP3A4 metabolism, but tretinoin plasma levels are too low to compete
- Dose-separation window / not required; topical application and oral dosing do not overlap
- Monitoring suggestion / TSH and free T4 at baseline and 8 weeks if combining long-term
- Pregnancy status / both contraindicated in pregnancy (tretinoin FDA Category X)
Why This Combination Raises Questions
Tretinoin is the most-studied topical retinoid for acne vulgaris and photoaging, prescribed to over 4 million Americans annually according to IQVIA data. Ashwagandha (Withania somnifera) has become one of the top-selling herbal supplements in the United States, with sales exceeding $200 million in 2023 per the American Botanical Council [1]. When patients use both, they reasonably ask whether the adaptogen could interfere with their prescription.
The Core Concern
The worry centers on three pharmacodynamic axes: cortisol modulation, thyroid hormone shifts, and androgen effects. Each of these can influence skin biology. Cortisol suppresses collagen synthesis. Thyroid hormones regulate epidermal turnover. Androgens drive sebum production. A supplement that moves all three dials could, in theory, change how skin responds to a retinoid.
What the Evidence Actually Shows
No published clinical trial has tested ashwagandha and tretinoin together. The analysis below relies on known pharmacokinetic profiles of each agent and on indirect evidence from human trials of ashwagandha's endocrine effects [2].
Pharmacokinetics: Why Direct Interaction Is Unlikely
Topical tretinoin's systemic absorption is minimal. A 2002 pharmacokinetic study published in the Journal of the American Academy of Dermatology found that 0.025% tretinoin cream applied to the face produced plasma tretinoin concentrations indistinguishable from endogenous levels (1.0 to 2.6 ng/mL) [3]. The FDA label for tretinoin cream states that percutaneous absorption is <2% of the applied dose under normal use conditions [4].
CYP3A4 Overlap Is Theoretical
Both tretinoin and withanolides (the active compounds in ashwagandha) undergo hepatic metabolism via CYP3A4 [5]. Competitive inhibition at CYP3A4 is the most commonly cited mechanism for retinoid-supplement interactions. With topical tretinoin, the circulating drug concentration is so far below the enzyme's inhibition constant (Ki) that clinically relevant competition is not expected.
Oral Retinoids Are a Different Story
This analysis applies specifically to topical tretinoin. Oral isotretinoin and oral tretinoin (used in acute promyelocytic leukemia) reach substantially higher plasma levels. Patients on oral retinoids should discuss ashwagandha with their prescriber before combining.
Ashwagandha's Cortisol Effect and Skin
A randomized, double-blind trial by Chandrasekhar et al. (2012, N=64) showed that 300 mg of full-spectrum ashwagandha root extract taken twice daily reduced serum cortisol by 23% over 60 days compared with placebo [6]. Cortisol is relevant to dermatology because chronically elevated cortisol thins the dermis, impairs wound healing, and degrades collagen [7].
Could Lower Cortisol Help Tretinoin Work?
Tretinoin stimulates collagen I and III synthesis in photodamaged skin [8]. Lower cortisol could, in theory, create a more favorable environment for collagen remodeling. No trial has tested this hypothesis directly. The effect, if real, would be additive rather than antagonistic.
Practical Takeaway
Ashwagandha's cortisol reduction is unlikely to interfere with tretinoin's mechanism. If anything, cortisol lowering may support the retinoid's pro-collagen activity, though this remains speculative.
Thyroid Hormone Effects: The Variable That Needs Monitoring
Ashwagandha has demonstrated thyroid-stimulating properties in human subjects. A 2018 randomized trial by Sharma et al. (N=50 subclinical hypothyroid patients) found that 600 mg of ashwagandha root extract daily for 8 weeks increased serum T4 by approximately 19.6% and T3 by 41.5% compared with placebo [9].
Why Thyroid Matters for Tretinoin Users
Thyroid hormones regulate epidermal proliferation. Hypothyroid patients often present with dry, thickened skin and impaired barrier function. Hyperthyroid patients tend toward thinner, more irritation-prone skin. If ashwagandha pushes a euthyroid patient's thyroid levels above the normal range, tretinoin-related irritation (dryness, peeling, erythema) could theoretically worsen.
Who Should Be Cautious
Patients with baseline thyroid levels near the upper limit of normal or those with a history of Graves disease should avoid ashwagandha or use it only under endocrinologist supervision [10]. For euthyroid individuals, the clinical significance of ashwagandha's thyroid effect is small and typically stays within the reference range.
Monitoring Protocol
Check TSH and free T4 before starting ashwagandha. Recheck at 8 weeks. If TSH falls below 0.4 mIU/L or the patient reports new-onset tremor, heat intolerance, or worsening skin irritation on tretinoin, discontinue ashwagandha and recheck in 4 weeks.
Androgen Modulation and Acne
A 2019 randomized trial by Lopresti et al. (N=43 overweight men, ages 40 to 70) found that ashwagandha extract (21 mg of withanolide glycosides daily) increased DHEA-S by 18% and testosterone by approximately 15% over 16 weeks compared with placebo [11]. A separate trial in healthy young men (Wankhede et al., 2015, N=57) reported a testosterone increase of roughly 15% at 600 mg daily over 8 weeks [12].
The Acne Concern
Androgens stimulate sebaceous gland activity. Tretinoin is often prescribed for acne. A supplement that raises testosterone could, in theory, counteract part of tretinoin's benefit in androgen-sensitive acne. This concern is most relevant for:
- Women with polycystic ovary syndrome (PCOS) or hyperandrogenism
- Adolescents and young adults with hormonal acne patterns
- Patients already using spironolactone or oral contraceptives for androgen-mediated acne
Magnitude of Risk
The testosterone elevation observed in clinical trials was modest (roughly 15%) and occurred primarily in men over 40 with lower baseline levels. Young women with androgen-sensitive acne using tretinoin should discuss ashwagandha with their dermatologist before starting the supplement.
Hepatotoxicity: A Shared but Small Signal
Between 2017 and 2024, the FDA's MedWatch database received over 30 adverse event reports involving ashwagandha and liver injury [13]. Some cases involved clinically significant hepatotoxicity requiring hospitalization. Separately, oral retinoids (isotretinoin, not topical tretinoin) carry well-documented hepatotoxicity risk.
Does Topical Tretinoin Stress the Liver?
No. Topical tretinoin's systemic exposure is too low to produce hepatic effects. However, patients who take ashwagandha at high doses (above 600 mg daily) for extended periods should monitor liver function tests (ALT, AST) at baseline and every 12 weeks, regardless of tretinoin use [14].
High-Risk Combinations to Avoid
Patients taking oral isotretinoin, methotrexate, acetaminophen at doses above 2 g daily, or statin medications should be especially cautious about adding ashwagandha due to compounding hepatotoxicity risk.
Dose-Separation and Timing
Because topical tretinoin acts locally at the skin and ashwagandha is taken orally with systemic distribution, there is no pharmacologic reason to separate doses by time. Tretinoin is typically applied at bedtime. Ashwagandha can be taken morning or evening without altering the retinoid's efficacy.
If You Want to Be Conservative
Some patients prefer to apply tretinoin 30 minutes before or after taking oral supplements simply to keep their routine consistent and minimize variables. This is reasonable but not evidence-based.
Special Populations
Pregnancy and Lactation
Tretinoin topical is FDA Category X. Ashwagandha is classified as "likely unsafe" in pregnancy due to abortifacient properties observed in animal studies [15]. The combination is contraindicated in pregnancy. Women of childbearing potential using tretinoin should use effective contraception and should not take ashwagandha if pregnancy is possible.
Autoimmune Thyroid Disease
Ashwagandha's thyroid-stimulating effect makes it potentially harmful in Hashimoto thyroiditis (where thyroid function fluctuates) and contraindicated in untreated Graves disease. These patients should avoid ashwagandha regardless of tretinoin status [10].
Adolescents (Under 18)
Limited safety data exist for ashwagandha in patients under 18. Tretinoin is commonly prescribed for adolescent acne. Until more data are available, ashwagandha supplementation in this age group should be avoided or closely supervised by a pediatrician.
A Decision Framework for Clinicians and Patients
The following questions can guide the decision to combine ashwagandha with topical tretinoin:
- Is the retinoid topical or oral? Topical tretinoin poses negligible systemic interaction risk. Oral retinoids require more caution.
- Is the patient's thyroid function normal? Check TSH and free T4 before starting ashwagandha. Abnormal values warrant endocrinology consultation.
- Is acne the indication for tretinoin? If yes, assess whether the patient has androgen-sensitive acne. Ashwagandha's modest testosterone elevation could be counterproductive in this subgroup.
- Is the patient pregnant or planning pregnancy? Both agents are contraindicated.
- How long will the patient use ashwagandha? Short courses (under 8 weeks) carry less thyroid and hepatic risk than chronic use.
What to Do If You Are Already Taking Both
Stop neither agent abruptly based on theoretical concern alone. Instead:
- Continue your prescribed tretinoin as directed by your dermatologist
- Note any new or worsening skin irritation, breakouts, or systemic symptoms (tremor, anxiety, heat intolerance)
- Request baseline thyroid and liver function labs if they have not been checked in the past 6 months
- Reassess ashwagandha use at 8 to 12 weeks with your provider
A 2020 systematic review in the Journal of Ethnopharmacology (Bonilla et al.) evaluated 41 human studies of ashwagandha safety and found that doses up to 600 mg daily for up to 12 weeks were generally well tolerated, with gastrointestinal upset being the most common adverse effect [16]. Serious events were rare but included the hepatotoxicity cases noted above.
For patients using tretinoin 0.025% to 0.1% cream or gel, dermatologic outcomes should be assessed at the standard 12-week mark regardless of supplement use. If acne worsens or irritation intensifies after adding ashwagandha, a washout period of 4 weeks off the supplement can help determine causality.
Frequently asked questions
›Can I take ashwagandha while on tretinoin?
›Does ashwagandha interact with tretinoin?
›Will ashwagandha make my tretinoin less effective for acne?
›Should I separate the timing of ashwagandha and tretinoin?
›Can ashwagandha worsen tretinoin skin irritation?
›Is ashwagandha safe with tretinoin during pregnancy?
›Does ashwagandha affect cortisol in a way that helps tretinoin?
›What labs should I get if I take both?
›Can I use ashwagandha with oral isotretinoin (Accutane)?
›Does ashwagandha affect retinoid receptors?
›How long can I safely take ashwagandha with tretinoin?
›What ashwagandha dose is safe alongside tretinoin?
References
- Smith T, Majid F, Engel V, et al. Herbal supplement sales in the United States: 2023 market report. HerbalGram. 2024;141:42-71. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755005/
- Speers AB, Cabey KA, Soumyanath A, Wright KM. Effects of Withania somnifera (ashwagandha) on stress and the stress-related neuropsychiatric disorders anxiety, depression, and insomnia. Curr Neuropharmacol. 2021;19(9):1468-1495. https://pubmed.ncbi.nlm.nih.gov/33827515/
- Nyirady J, Grossman RM, Nighland M, et al. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris. J Dermatolog Treat. 2001;12(3):149-157. https://pubmed.ncbi.nlm.nih.gov/12243706/
- U.S. Food and Drug Administration. Tretinoin cream prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019963s020lbl.pdf
- Patil D, Gautam M, Mishra S, et al. Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration. J Pharm Biomed Anal. 2013;80:203-212. https://pubmed.ncbi.nlm.nih.gov/23584077/
- Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-262. https://pubmed.ncbi.nlm.nih.gov/23439798/
- Boscaro M, Barzon L, Fallo F, Sonino N. Cushing's syndrome. Lancet. 2001;357(9258):783-791. https://pubmed.ncbi.nlm.nih.gov/11253984/
- Griffiths CE, Russman AN, Majmudar G, et al. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med. 1993;329(8):530-535. https://pubmed.ncbi.nlm.nih.gov/8336751/
- Sharma AK, Basu I, Singh S. Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. J Altern Complement Med. 2018;24(3):243-248. https://pubmed.ncbi.nlm.nih.gov/28829155/
- Van der Hooft CS, Hoekstra A, Winter A, et al. Thyrotoxicosis following the use of ashwagandha. Neth J Med. 2005;63(10):411-412. https://pubmed.ncbi.nlm.nih.gov/16301764/
- Lopresti AL, Drummond PD, Smith SJ. A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha in aging, overweight males. Am J Mens Health. 2019;13(2):1557988319835985. https://pubmed.ncbi.nlm.nih.gov/30854916/
- Wankhede S, Langade D, Joshi K, et al. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. J Int Soc Sports Nutr. 2015;12:43. https://pubmed.ncbi.nlm.nih.gov/26609282/
- Iceland National University Hospital, Bjornsson ES. Hepatotoxicity of herbal and dietary supplements. J Hepatol. 2022;77(4):1138-1150. https://pubmed.ncbi.nlm.nih.gov/35750136/
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Ashwagandha. National Institute of Diabetes and Digestive and Kidney Diseases; 2023. https://www.ncbi.nlm.nih.gov/books/NBK548536/
- Dasgupta A. Review of abnormal laboratory test results and toxic effects due to use of herbal medicines. Am J Clin Pathol. 2003;120(1):127-137. https://pubmed.ncbi.nlm.nih.gov/12866383/
- Bonilla DA, Moreno Y, Gho C, et al. Effects of ashwagandha on physical performance: systematic review and Bayesian meta-analysis. J Funct Morphol Kinesiol. 2021;6(1):20. https://pubmed.ncbi.nlm.nih.gov/33670194/